EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Shares Outstanding (2010 - 2026)

EyePoint (EYPT) posted Shares Outstanding (Entity) of $85999.0 for Q1 2026, up 17.4% sequentially from $73251.0 in Q4 2025, and down 99.88% YoY from $68.8 million in Q1 2025.

Analysis

EyePoint (EYPT) Shares Outstanding (2010 - 2026) Analysis & Trends

EyePoint has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $85999.0 in Q1 2026.

  • Quarterly Shares Outstanding (Entity) fell 99.88% year-over-year to $85999.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85999.0 (down 99.88% YoY) and the FY2025 annual result came in at $73251.0, up 30.11% from the prior year.
  • Shares Outstanding (Entity) rose to $85999.0 in Q1 2026 per EYPT's latest filing, from $73251.0 in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $68.8 million in Q1 2025 and troughed at $52913.0 in Q1 2024.
  • A 5-year average of $26.7 million and a median of $34.1 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) surged 129946.22% in 2025, then plunged 99.88% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $34.1 million in 2022, then gained by 14.15% to $38.9 million in 2023, then tumbled by 99.86% to $56298.0 in 2024, then surged by 30.11% to $73251.0 in 2025, then climbed by 17.4% to $85999.0 in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $85999.0, $73251.0, and $70168.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 86.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86.54 Mn
Mar 31, 2026 86.00 Mn
Dec 31, 2025 73.25 Mn
Sep 30, 2025 70.17 Mn
Jun 30, 2025 69.93 Mn
Mar 31, 2025 69.77 Mn
Dec 31, 2024 56.30 Mn
Sep 30, 2024 54.45 Mn
Jun 30, 2024 53.21 Mn
Mar 31, 2024 52.91 Mn
Dec 31, 2023 38.90 Mn
Sep 30, 2023 38.34 Mn
Jun 30, 2023 37.58 Mn
Mar 31, 2023 37.49 Mn
Dec 31, 2022 37.32 Mn
Sep 30, 2022 37.34 Mn
Jun 30, 2022 37.32 Mn
Mar 31, 2022 37.25 Mn
Dec 31, 2021 28.76 Mn
Sep 30, 2021 28.77 Mn